Stock Fundamentals

Company Information

Company Name
Kamada
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: IL0010941198
CIK: 0001567529
CUSIP: M6240T109
Currency: USD
Full Time Employees: 462
Phone: 972 8 940 6472
Fiscal Year End: December
IPO Date: May 31, 2013
Description:

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; and Echis coloratus and Vipera palaestinae Antiserum to treat snake bite. The company also distributes biopharmaceutical products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for various immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for prevention of hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX to treat hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for salmonella typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; RYPLAZIM for hypoplasminogenemia; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.

Address:

2 Holzman Street, Rehovot, Israel, 7670402

Directors & Officers

Name Title Year Born
Mr. Amir London Chief Executive Officer 1969
Mr. Chaime Orlev Chief Financial Officer 1970
Mr. Eran Nir Chief Operating Officer 1973
Mr. Jon R. Knight Vice President of US Commercial Operations 1966
Mr. Boris Gorelik Vice President of Business Development & Strategic Programs 1982
Mr. David Tsur Co-Founder & Independent Deputy Chairman of the Board 1950
Mr. Nir Livneh B.A., L.L.B. VP, General Counsel & Corporate Secretary 1979
Ms. Hanni Neheman Vice President of Marketing & Sales 1970
Ms. Liron Reshef Vice President of Human Resources 1972
Ms. Shavit Beladev Vice President of Kamada Plasma 1971

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
State of Tennessee, Treasury Department 0.00 Jun 30, 2023 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 57.69M
Shares Float: 9.37M
% Insiders: 719.50%
% Institutions: 4,854.30%
Short % Float: 0.43%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 ARK Israel Innovative Technology ETF 263.30K 0.46% ▲ 0.00% May 31, 2026
2 DFA International Small Company I 198.87K 0.34% ▲ 0.01% Apr 30, 2026
3 DFA International Core Equity 2 I 98.55K 0.17% ▲ 0.00% Apr 30, 2026
4 Dimensional International Sm Cp Val ETF 54.06K 0.09% ▲ 4.49% May 29, 2026
5 Dimensional International Small Cap ETF 42.00K 0.07% ▲ 0.00% May 29, 2026
6 iShares Nasdaq US Biotech ETF USD Acc 41.65K 0.07% ▲ 0.00% May 29, 2026
7 Fidelity Nasdaq Composite Index 37.50K 0.07% ▲ 0.00% Apr 30, 2026
8 Dimensional International Core Eq 2 ETF 28.08K 0.05% ▲ 0.00% May 29, 2026
9 DFA International Small Cap Value I 27.01K 0.05% ▲ 552.63% Apr 30, 2026
10 Dimensional Global Trgtd Value USD Acc 25.94K 0.05% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $361.03M
Trailing P/E: 21.26
Forward P/E: 18.18

Financial Highlights

Market Cap: $430.15M
EBITDA: $38.91M
P/E Ratio: $21.26
PEG Ratio: $0.73
Book Value: $4.50
Dividend/Share: $0.25
Dividend Yield: 3.36%
Earnings/Share: $0.35
Profit Margin: 11.21%
Operating Margin: 15.37%
ROA (TTM): 4.19%
ROE (TTM): 7.97%
Revenue (TTM): $181.68M
Revenue/Share (TTM): $3.12
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 2.80%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.07x 0.01x 0.29x 30.36x 0.05x
2024-12-31 3.73x 0.01x 0.30x 30.38x 0.06x
2023-12-31 3.43x 0.01x 0.31x 7.75x 0.07x
2022-12-31 1.84x 0.10x 0.45x 4.96x 1.70x
2021-12-31 2.41x 0.12x 0.45x -2.46x 5.29x
2020-12-31 7.13x 0.01x 0.15x 72.32x 0.05x
2019-12-31 4.39x 0.01x 0.22x 77.76x 0.06x
2018-12-31 4.70x 0.01x 0.19x 58.87x 0.05x
2017-12-31 3.30x 0.02x 0.27x 90.78x 0.18x
2016-12-31 2.83x 0.03x 0.33x -46.36x -0.90x
2015-12-31 3.51x 0.00x 0.29x -12.23x -0.03x
2014-12-31 3.16x 0.10x 0.32x -3.60x -1.02x
2013-12-31 3.61x 0.18x 0.35x 1.17x 2.01x
2012-12-31 2.39x 0.85x 0.68x 1.26x 3.36x
2011-12-31 2.93x 0.99x 0.73x -0.61x 8.30x
2010-12-31 3.59x 0.00x 0.71x -2.13x 0.00x
2009-12-31 4.92x 0.00x 0.52x -4.05x -0.01x
2008-12-31 2.81x 0.11x 0.70x -3.71x -0.10x
2007-12-31 N/A N/A N/A -36.85x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KMDA.US!